by Kristin Cantu on January 10, 2010
by Childrens Hospital Boston staff on December 6, 2009
Here’s a quick look at what Thrive was up to last week.
Yoga is thought to have many healing powers, but is fighting eating disorders one of them? One patient tells her story of how brain stimulation helps keep her epileptic seizures at bay. Children’s professionalism and ethical practice expert talks about the changing mammography guidelines and gives insight into the health care reform. Children’s Dr. Sharon Levy discusses whether or not home-based drug kits are useful on the MSNBC show “Dr. Nancy.” The National Institute of Health announced 13 new government-approved embryonic stem cell lines, 11 of which were developed at Children’s. The HealthMap team gave us our weekly H1N1 update. Did you know that children with RSV are more likely to be hospitalized than those with seasonal flu? Our Mediatrician sings his praises of Guitar Hero but adds a warning about appropriate lyrics. Good Morning America features Children’s research on autism and facial recognition.
by Childrens Hospital Boston staff on December 2, 2009
Stem cell researcher Willy Lensch
By M. William Lensch, PhD, from the Stem Cell Program at Children’s Hospital Boston
At just a little after 12:30 p.m. EST today we reached the end of a very long road. That was when the NIH announced that the first human embryonic stem cell lines (hESC) had been approved for federal funding eligibility under the rules put forth in President Obama’s executive order from earlier this year. A small group of us here in George Daley’s lab were listening in to the NIH press conference over the speaker phone. I couldn’t help but clap my hands and cheer! A lot of us have worked toward this moment for a long time. Full story »
by Melissa Jeltsen on December 2, 2009
The National Institutes of Health today announced 13 new government-approved embryonic stem cell lines that scientists can get NIH funding to work with. The newly approved lines–11 of which were developed right here at Children’s–were derived from embryos donated by couples undergoing in-vitro fertilization, and all meet the NIH’s strict ethical standards requiring informed consent from donor couples.
With more lines available, and additional approvals expected to come soon, the pace of stem cell research is expected to pick up — and with it, a better understanding of human diseases and better therapies for treating them.
Read researcher Willy Lensch’s first-person post about what this means to the field of stem cell research – and to him personally.
by Childrens Hospital Boston staff on July 7, 2009
Andres Trevino has a very personal take on the NIH’s recent stem cell guidelines. Here, he talks about his son Andy’s rare genetic condition, the daughter whose stem cells saved Andy’s life and the potential stem cells hold for curing other diseases.
Left to right, Tania, Paulina, Sofia, Andres and Andy Trevino
My wife is a carrier of a genetic condition that causes the immune system to fail. Ten years ago, we found out the hard way, after the birth of our son, Andy. He had his first life-threatening infection 48 hours after he was born in Mexico City and it took us 19 difficult months to find him a diagnosis. Full story »
by Matt Cyr on July 7, 2009
George Daley, MD, PhD, associate director of Children’s Stem Cell Research Program, comments on the new stem cell regulations in the NY Times and USA Today.
by Matt Cyr on July 6, 2009
